In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
Brexit: Industry should keep Timelines for Batch Testing Facilities

Brexit: Industry should keep Timelines for Batch Testing Facilities

by In2Pharma | Nov 4, 2019 | News

Europe In a reminder sent out to stakeholders the EMA points out that MAHs should use the remaining time to Brexit to complete all necessary preparations. This means that by 1 January 2020 all batch testing sites must be fully transferred to the remaining EU27 Member...

EU rules for batch testing of medicinal products after BREXIT

by In2Pharma | Feb 28, 2019 | News

European Union In light of the withdrawal of the United Kingdom from the European Union, the European Commission has published a letter on the rules for batch testing of medicinal products after the Brexit. The competent authorities may allow marketing authorisation...

Recent Posts

  • Update Belgian FAQ on nutrition and health claims
  • Simplification of disclaimers for promotional materials
  • REACH Microplastics Restriction: What You Need to Know – and Do – Today!
  • “Successive GMP certificate” applications
  • New contact form for questions on variations and renewals from 1 June 2025

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België